NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with ...
The family of a man with schizophrenia facing two counts of attempted murder is bracing for an aspect of the criminal justice ...
A CHART topping singer has revealed the tragic loss of her little brother after his “courageous” decade-long battle.
New research from the Institute of Psychiatry, Psychology & Neuroscience, supported by the Population Mental Health ...
A witness with schizophrenia was the reason a prosecutor allowed a man to plead guilty to manslaughter and get only six years ...
Coffee, probably the world’s favorite perker-upper and pooper-shaker, can have surprising benefits to those with severe ...
Panelists discuss how relapse is one of the most significant challenges in schizophrenia management, often resulting in ...
Panelists discuss how schizophrenia typically evolves through distinct phases—from first-episode psychosis to chronic illness ...
Dual art therapy, combining music and painting, significantly improved symptoms, cognitive function, and quality of life in ...
To understand iclepertin's safety and efficacy, researchers pooled phase 3 trial data, focusing on cognition in CIAS patients.
Cobenfy’s efficacy at treating the symptoms of patients with psychosis may vary between subgroups, according to a post-hoc ...
GRIN2A gene mutations emerge as single-gene cause of childhood schizophrenia, anxiety, and mood disorders, potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback